Trials / Unknown
UnknownNCT05894122
Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®)
Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®) in the Context of Metabolic Diseases and, in Particular, Pediatric Monitoring of Phenylketonuria
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 3 Months – 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim is to demonstrate a new application for a blood collection device. This device is already widely used in pharmacology. It is not currently used for metabolic diseases. Its ease of use enables repeated sampling at home. What's more, the device can be sent by post, making it ideally suited to the needs of this cohort of children, whose phenylalanine levels need to be monitored very regularly.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | DM-DIV MITRA® | Comparison of phenylalanine concentrations in the new device with those in the current device (blotter). |
Timeline
- Start date
- 2023-12-13
- Primary completion
- 2025-12-12
- Completion
- 2025-12-12
- First posted
- 2023-06-08
- Last updated
- 2023-12-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05894122. Inclusion in this directory is not an endorsement.